Downregulation of Fer induces PP1 activation and cell-cycle arrest in malignant cells

O Pasder1, S Shpungin, Y Salem

  • 1The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel.

Oncogene
|May 30, 2006
PubMed

Insights

Fer, a tyrosine kinase, is crucial for malignant cell-cycle progression. Inhibiting Fer halts cancer cell proliferation by activating the retinoblastoma protein (pRB), offering a potential cancer intervention target.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Fer is an intracellular tyrosine kinase found in both the nucleus and cytoplasm.
  • Cell-cycle progression is a fundamental process often dysregulated in malignant cells.

Purpose of the Study:

  • To investigate the role of Fer in cell-cycle progression in cancer cells.
  • To elucidate the molecular mechanisms by which Fer influences cell-cycle regulation.
  • To evaluate Fer as a potential therapeutic target for cancer intervention.

Main Methods:

  • RNA interference (RNAi) was used to decrease Fer levels in prostate and breast carcinoma cells.
  • Western blotting and co-immunoprecipitation were employed to analyze protein levels, phosphorylation states, and interactions.
  • Amino-acid sequence analysis identified potential protein phosphatase 1 (PP1) binding motifs within Fer.

Main Results:

  • Decreasing Fer levels via RNAi impeded cancer cell proliferation and caused G0/G1 phase arrest.
  • Fer knockdown led to retinoblastoma protein (pRB) activation, evidenced by hypo-phosphorylation at CDK4 and CDK2 sites.
  • Fer interacts with and regulates the activity of the pRB phosphatase PP1alpha, with Fer downregulation potentiating PP1alpha activity.

Conclusions:

  • Fer is essential for cell-cycle progression in malignant cells.
  • Fer regulates pRB dephosphorylation through its interaction with PP1alpha.
  • Fer represents a promising molecular target for novel cancer therapies.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...